| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 13 | |
| #2 | China | 8 | |
| #3 | Hong Kong | 8 | |
| #4 | United States | 8 | |
| #5 | WIPO (World Intellectual Property Organization) | 8 | |
| #6 | Canada | 7 | |
| #7 | Taiwan | 5 | |
| #8 | Australia | 4 | |
| #9 | Republic of Korea | 4 | |
| #10 | Brazil | 3 | |
| #11 | Japan | 3 | |
| #12 | Mexico | 3 | |
| #13 | Malaysia | 3 | |
| #14 | New Zealand | 3 | |
| #15 | Singapore | 3 | |
| #16 | Argentina | 2 | |
| #17 | Colombia | 2 | |
| #18 | Israel | 2 | |
| #19 | South Africa | 2 | |
| #20 | Costa Rica | 1 | |
| #21 | India | 1 | |
| #22 | Ukraine | 1 | |
| #23 | Uruguay | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Rothe Mike | 43 |
| #2 | Hettmann Thore | 40 |
| #3 | Wirtz Peter | 28 |
| #4 | Ruhe Jens | 28 |
| #5 | Zwick-Wallasch Esther | 23 |
| #6 | Borges Eric | 18 |
| #7 | Selle Kerstin | 16 |
| #8 | Treder Martin | 13 |
| #9 | Takayama Tomoko | 13 |
| #10 | Takizawa Takeshi | 13 |
| Publication | Filing date | Title |
|---|---|---|
| TW201706308A | Human anti-FGFR4 antibody | |
| EP3095465A1 | Combination of fgfr4-inhibitor and bile acid sequestrant | |
| US2015152193A1 | Axl antibodies | |
| AU2013203603A1 | Activated HER3 as a marker for predicting therapeutic efficacy | |
| CN104136464A | Her3 inhibitor for modulating radiosensitivity | |
| EP2817335A1 | Combination of hb-egf binding protein and egfr inhibitor | |
| EP2601220A2 | Use of her3 binding agents in prostate treatment | |
| BRPI1013428A2 | humanized antibodies to axl | |
| EP2270053A1 | Humanized AXL antibodies | |
| CN101939336A | AXL antibodies | |
| CA2668295A1 | Fgfr4 antibodies |